Pro Share Advisors LLC Solid Biosciences Inc. Transaction History

Pro Share Advisors LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$0.43 - $1.24 $9,714 - $28,012	-22,591 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$0.74 - $1.79 $4,417 - $10,684	-5,969 Reduced 20.9%	22,591 $27,000
Q4 2021 Feb 08, 2022	BUY	$1.69 - $2.46 $48,266 - $70,257	28,560 New	28,560 $49,000
Q3 2021 Nov 12, 2021	SELL	$2.38 - $3.77 $36,816 - $58,318	-15,469 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$3.49 - $5.51 $53,986 - $85,234	15,469 New	15,469 $57,000
Q4 2020 Feb 09, 2021	SELL	$3.08 - $7.79 $32,213 - $81,475	-10,459 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$2.02 - $3.08 $527 - $803	-261 Reduced 2.43%	10,459 $21,000
Q2 2020 Aug 03, 2020	BUY	$2.1 - $3.42 $22,512 - $36,662	10,720 New	10,720 $31,000
Q1 2020 May 15, 2020	SELL	$2.31 - $4.43 $29,129 - $55,862	-12,610 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$2.82 - $12.9 $5,868 - $26,844	-2,081 Reduced 14.17%	12,610 $56,000
Q3 2019 Nov 12, 2019	BUY	$4.33 - $11.64 $13,280 - $35,699	3,067 Added 26.39%	14,691 $152,000
Q2 2019 Aug 13, 2019	SELL	$4.6 - $10.13 $7,994 - $17,605	-1,738 Reduced 13.01%	11,624 $67,000
Q1 2019 May 15, 2019	BUY	$7.19 - $32.37 $496 - $2,233	69 Added 0.52%	13,362 $123,000
Q4 2018 Feb 14, 2019	BUY	$21.32 - $46.34 $283,406 - $615,997	13,293 New	13,293 $356,000

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $36.5M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.